Behavioral and neurochemical changes induced by oxycodone differ between adolescent and adult mice.
Nonmedical use of the prescription opioid analgesic oxycodone is a major problem in the United States, particularly among adolescents and young adults. This study characterized self-administration of oxycodone by adolescent and adult mice, and how this affects striatal dopamine levels. Male C57BL/6J mice (4 or 10 weeks old) were allowed to acquire oxycodone self-administration (0.25 mg/kg per infusion) for 9 days, and then tested with varying doses of oxycodone (0, 0.125, 0.25, 0.5, and 0.75 mg/kg per infusion). On completion of the self-administration study, a guide cannula was implanted into the striatum of these mice. Six days later, microdialysis was conducted on the freely moving mouse. After collection of baseline samples, oxycodone was administered i.p. (1.25, 2.5, and 5.0 mg/kg) and samples were collected for 1 h after each dose. Adult mice self-administered significantly more oxycodone across the doses tested. After 1 week, basal striatal dopamine levels were lower in mice of both ages that had self-administered oxycodone than in yoked saline controls. Oxycodone challenge increased striatal dopamine levels in a dose-dependent manner in both age groups. Of interest, the lowest dose of oxycodone led to increased striatal dopamine levels in the mice that had self-administered oxycodone during adolescence but not those that self-administered it as adults. The lower number of infusions of oxycodone self-administered by adolescent mice, and their later increased striatal dopamine in response to the lowest dose of oxycodone (not found in adults), suggest differential sensitivity to the reinforcing and neurobiological effects of oxycodone in the younger mice.
Zhang
Yong
Y
The Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, NY 10065, USA. zhangyo@rockefeller.edu
Picetti
Roberto
R
Butelman
Eduardo R
ER
Schlussman
Stefan D
SD
Ho
Ann
A
Kreek
Mary Jeanne
MJ
D000375:Aging; D000704:Analysis of Variance; D000818:Animals; D016739:Behavior, Addictive; D003342:Corpus Striatum / Q000187:drug effects* / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D005108:Extinction, Psychological; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D015233:Models, Statistical; D010098:Oxycodone / Q000008:administration & dosage*; D012646:Self Administration
D010098:Oxycodone; D004298:Dopamine
Int J Addict. 1992 Nov;27(11):1313-23
1446964
J Pharmacol Exp Ther. 2005 Aug;314(2):596-602
15860573
Neurotoxicol Teratol. 2007 Jan-Feb;29(1):57-65
17184971
J Pharmacol Exp Ther. 1995 May;273(2):591-8
7752060
Neuroscience. 1998 Mar;83(1):169-76
9466407
Drug Alcohol Depend. 1999 Oct 1;56(3):205-12
10529022
Drugs. 2003;63(1):17-32
12487620
Eur J Pharmacol. 2005 Dec 28;528(1-3):119-23
16321380
Psychopharmacology (Berl). 2004 Sep;175(3):265-73
15098085
Pharmacol Biochem Behav. 2005 Mar;80(3):411-7
15740783
Synapse. 1995 Oct;21(2):140-8
8584975
J Pharmacol Exp Ther. 1995 Feb;272(2):781-5
7853194
Environ Health Perspect. 2003 Apr;111(4):395-401
12676589
Curr Drug Deliv. 2008 Jan;5(1):55-8
18220551
Brain Res. 2001 Dec 27;923(1-2):172-7
11743985
J Pharmacol Exp Ther. 1995 Feb;272(2):652-7
7853178
Brain Res Mol Brain Res. 1999 Mar 20;66(1-2):184-7
10095091
J Neurosci. 2006 Mar 8;26(10):2645-51
16525043
Pharmacol Biochem Behav. 2003 Mar;74(4):917-31
12667907
Neurotoxicol Teratol. 2007 Jul-Aug;29(4):458-65
17433619
Brain Res. 2000 Oct 20;881(1):69-72
11033095
Psychopharmacology (Berl). 2004 Jul;174(3):389-95
14740150
Eur J Pharmacol. 2006 Nov 21;550(1-3):95-106
17011546
Drugs. 1996 May;51(5):713-37
8861543
Eur J Pharmacol. 1992 Oct 20;221(2-3):227-34
1426002
Brain Res. 2002 Jan 11;924(2):141-50
11750899
Pharmacol Biochem Behav. 2001 Dec;70(4):475-89
11796147
Neuropsychopharmacology. 2008 Apr;33(5):1097-112
17593930
Synapse. 2003 Dec 1;50(3):191-9
14515336
Neuropsychopharmacology. 2007 Mar;32(3):625-37
16794567
Physiol Behav. 2000 Feb;68(4):487-93
10713288
Dev Neurosci. 1999;21(1):43-9
10077701
Neuropsychopharmacology. 2005 Apr;30(4):705-12
15496937
Psychopharmacology (Berl). 2003 Sep;169(2):141-9
12764575
Behav Brain Res. 1982 Mar;4(3):279-88
6277348
Brain Res Dev Brain Res. 1995 Nov 21;89(2):167-72
8612321
J Neurochem. 1989 May;52(5):1582-9
2709014
Brain Res. 1991 Dec 6;566(1-2):348-50
1814554
Behav Neural Biol. 1979 Aug;26(4):401-15
574000
Neurosci Lett. 1987 Oct 16;81(1-2):227-31
3696469
Neuropsychopharmacology. 2007 Mar;32(3):700-9
16794562
Physiol Behav. 2002 Sep;77(1):107-14
12213508
Neuropsychopharmacology. 2007 Mar;32(3):607-15
16823391
Neuropsychopharmacology. 2008 Mar;33(4):739-48
17507913